Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-28T05:53:08.378Z Has data issue: false hasContentIssue false

Alcohol Misuse in People with Schizophrenia: Findings from the Paddi (psychiatric and Addictive Dual Diagnosis in Italy) Study

Published online by Cambridge University Press:  16 April 2020

G. Carrà
Affiliation:
Department Mental Health Sciences, Royal Free and University College Medical School, London, UK
G. Segagni Lusignani
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Pavia, Italy
P. Sciarini
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Pavia, Italy
P. Borrelli
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Pavia, Italy
I. Popa
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Pavia, Italy
C. Montomoli
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Pavia, Italy
M. Clerici
Affiliation:
Department of Neurosciences and Biomedical Technologies, University of Milan Bicoccca, Milan, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Comorbid alcohol misuse in schizophrenia and severe mental illness is associated with significant clinical, social and legal problems. An epidemiologically informed approach to planning service delivery requires an understanding of which clinical populations are at particularly high risk for alcohol misuse. Most evidence about the prevalence of this comorbidity comes from the USA, Canada and Australia, and, though at a different pace, also from Europe.

Method:

A cross-sectional survey design has been used to determine the prevalence In Italy of comorbid drug and alcohol and any - even minor - mental disorders. Staff ratings was used to assess comorbid substance use.

Results:

Though overall dual diagnosis prevalence is around 2%, significantly higher rates were found in inner cities. Furthermore significant differences were found between different geographical areas (Northern vs. Centre vs. Southern Italy). Peculiar diagnostic subgroups showed higher risk to develop such comorbid condition, whilst a number of clinical and sociodemographic variables, including area of residence, were associated with the risk to develop a dependence syndrome.

Conclusions:

Sampling and assessment procedures are major limitations which might explain the lower rates as compared with the current Anglo-Saxon literature. However, such variability emphasizes also that high comorbid alcohol misuse rates are not necessarily the direct result of biological features inherent in schizophrenia, but that social factors play an important role. Finally, a number of risk factors associated with dual diagnosis could build up an evidence base about the nature of their substance use, providing targeted service planning and policy making.

Type
S62-02
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.